Antidiuretic Hormone Market

Global Antidiuretic Hormone Market Size, Share and Trends Analysis Report, By Type (Intravenous Injection, Intramuscular Injection, and Subcutaneous Injection), By Application (Anti-Diuretic Hormone Deficiency, Vasodilatory Shock, Gastrointestinal Bleeding, and Ventricular Tachycardia & Fibrillation), Forecast (2021-2027)
    Update Available - Forecast 2024-2030   

Published: Jul 2023 | Report Code: OMR2025220 | Category : Pharmaceuticals | Delivery Format: /

The global antidiuretic hormone market is anticipated to grow at a significant CAGR during the forecast period (2021-2027). Antidiuretic hormone is also known as arginine vasopressin, secreted by the posterior pituitary gland and the secretion of ADH is controlled in the hypothalamus due to the presence of osmoreceptors. Antidiuretic is a class of drugs used to control the water balance in the body especially when a person is suffering from diabetes insipidus (DI). 

The market is driven by the rising prevalence of diabetes insipidus and the rise in obesity in the young generation. The increasing geriatric population across the globe and growing awareness regarding the usage of antidiuretic hormone is expected to boost the growth of the market. Additionally, the R&D processes to study antidiuretic drugs and their application in the treatment and management of diabetes insipidus is further anticipated to witness a lucrative growth opportunity for the global antidiuretic hormone market during the forecast period.

Furthermore, the key vendors present in the global antidiuretic hormone market include Novartis International AG, Pfizer Inc., Fresenius SE & Co. KGaA, Par Pharmaceutical, Inc., among others. These players adopt enormous strategies to remain competitive in the market during the forecast period. The strategies include product launches, technological advancement, research & developments, partnership & collaboration, market expansion, and others. For instance, in May 2020, Dr Reddy’s Laboratories, a pharmaceutical company announced the launch of desmopressin acetate injection USP 4 mcg/ml in the US pharmaceutical market. Desmopressin acetate is an antidiuretic hormone and is a synthetic analog of the natural pituitary hormone 8-arginine vasopressin that affects renal water conversation.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered
  • Regions Covered- Globally

Competitive Landscape- Novartis, Pfizer, Fresenius Kabi, Par Pharmaceuticals, Ferring Pharmaceuticals, Astellas Pharma, and others.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominates the market in base year?
  • Which segment and region will project fastest growth in the market?
  • How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Antidiuretic Hormone Market Report Segment

By Type

o Intravenous Injection 

o Intramuscular Injection 

o Subcutaneous Injection 

By Application

o Anti-Diuretic Hormone Deficiency

o Vasodilatory Shock 

o Gastrointestinal Bleeding 

o Ventricular Tachycardia & Fibrillation 

Global Antidiuretic Hormone Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Rest of Europe 

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific 

Rest of the World